Afnox Pharma Private Limited
About Afnox Pharma Private Limited
Data last updated:
Afnox Pharma Private Limited is a private limited company based in Siliguri, West Bengal, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 12 March 2023.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U21002WB2023PTC260324.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.5 Lakh. It is led by directors Taskeen Fatma and Mohammad Adil Afsar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Siliguri, West Bengal.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.86 Lakh, a growth of 143% compared to the previous year. For the same year it recorded a net loss of ₹89,516 (net margin -18.4%) and EBITDA of -₹53,125 (EBITDA margin -10.9%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Chandana Saha, Saktighar Upper Colony, Siliguri, West Bengal, India – 734005
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Afnox Pharma Private Limited
The main business activity of Afnox Pharma is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Afnox Pharma Private Limited FY 2025 filings available
Afnox Pharma Private Limited reported revenue of ₹4.86 Lakh (up 143% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Afnox Pharma Private Limited
Revenue rose 143% in the latest year. EBITDA rose 19% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Afnox Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹53,125 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹89,516 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Afnox Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -10.9% | •••• | •••• |
| Net Profit Margin | -18.4% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Afnox Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Afnox Pharma Private Limited
Afnox Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Human health activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maitri Medicare Private Limited | ₹4.92 Lakh (FY 2025) | •••• | •••• | •••• | Sangli, Maharashtra, India | |
| Pivotx Evolve & Thrive Private Limited | ₹4.92 Lakh (FY 2025) | •••• | •••• | •••• | Secunderabad, Telangana, India | |
| Jainam Healthcare Services Limited | ₹4.9 Lakh (FY 2025) | •••• | •••• | 195.0% | •••• | Mumbai, Maharashtra, India |
| Lotus Elegance Private Limited | ₹4.9 Lakh (FY 2024) | •••• | •••• | -78.0% | •••• | Bangalore, Karnataka, India |
| Jayamaya Healthcare Services Private Limited | ₹4.88 Lakh (FY 2025) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Afnox Pharma Private Limited this company | ₹4.86 Lakh (FY 2025) | •••• | •••• | 143.0% | •••• | Siliguri, West Bengal, India |
| Dr Ginwalla Ayurvedic Arthritis Solutions Private Limited | ₹4.83 Lakh (FY 2025) | •••• | •••• | -25.0% | •••• | Mumbai, Maharashtra, India |
| Akankshit Healthcare Services Private Limited | ₹4.83 Lakh (FY 2025) | •••• | •••• | •••• | Jaipur, Rajasthan, India | |
| Ahmednagar Arogyasadan Medical Research Private Limited | ₹4.82 Lakh (FY 2024) | •••• | •••• | •••• | Ahmednagar, Maharashtra, India | |
| Rehabkart Private Limited | ₹4.82 Lakh (FY 2025) | •••• | •••• | -30.0% | •••• | Delhi, India |
| Abs Humanity Foundation | ₹4.81 Lakh (FY 2025) | •••• | •••• | 3457.0% | •••• | Navi Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Afnox Pharma by revenue in the same principal business activity (Human health activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Afnox Pharma Private Limited
Afnox Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Taskeen Fatma | Director | 12 Mar 2023 | 3 Years 6 Months | Current |
| Mohammad Adil Afsar | Director | 12 Mar 2023 | 3 Years 6 Months | Current |
Charges & Borrowings of Afnox Pharma Private Limited
Afnox Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Afnox Pharma Private Limited
Employment history and EPFO contributions of people linked to Afnox Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Afnox Pharma Private Limited
Afnox Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Mohammad Adil Afsar was appointed as Director on 12 Mar 2023.
Credit Ratings, Litigation & Regulatory Alerts for Afnox Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Afnox Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Afnox Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Afnox Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Afnox Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Afnox Pharma Private Limited
Afnox Pharma is an active private limited company based in Siliguri, West Bengal, India. The company works in paper and paper products, within the paper industry. It was incorporated on 12 March 2023 (3+ years old) and is registered under CIN U21002WB2023PTC260324.
Afnox Pharma reported revenue of ₹4.86 Lakh for FY 2025 (up 143% YoY).
Afnox Pharma has 2 current directors:
- Taskeen Fatma - Director
- Mohammad Adil Afsar - Director
Afnox Pharma reported a net loss of ₹89,516 (net margin -18.4%) and EBITDA of -₹53,125 (EBITDA margin -10.9%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Afnox Pharma is U21002WB2023PTC260324. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Afnox Pharma was incorporated on 12 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Afnox Pharma by revenue are Maitri Medicare Private Limited, Pivotx Evolve & Thrive Private Limited, Jainam Healthcare Services Limited, Lotus Elegance Private Limited, Jayamaya Healthcare Services Private Limited and 5 more, all in the same principal business activity (Human health activities).
Mohammad Adil Afsar was appointed as Director on 12 Mar 2023. Taskeen Fatma was appointed as Director on 12 Mar 2023.
The registered office of Afnox Pharma is at CO Chandana Saha, Saktighar Upper Colony, Siliguri, West Bengal, India – 734005.
Afnox Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3.5 Lakh.
Afnox Pharma operates in the paper industry, in the paper and paper products segment.